Press release
Genotyping Market Size to Hit US$ 79,407.14 million by 2028
Genotyping is identifying the DNA sequence, or genotype, at particular locations across an individual's genome. In linkage and association studies, sequence variations can be employed as markers to find the genes responsible for specific characteristics or diseases. Understanding the relationship between genotypes and phenotypes requires knowledge of genotyping. Compared to a reference sequence from the general population or a specific subgroup, an individual genome is recognized as a distinct variant. The growth of the Genotyping market is primarily attributed to the use of genotyping in drug development for genetic and rare diseases, technological advancements, and rising R&D investments in pharmaceutical and biotechnology.Download PDF Brochure: https://www.theinsightpartners.com/sample/TIPHE100001166/?utm_source=OpenPR&utm_medium=10357
F. Hoffmann-La Roche Ltd., Integrated DNA Technologies, Inc. (Danaher), Qiagen, Merck KGaA, Eurofins Genomics, Thermo Fisher Scientific Inc., BioTek Instruments, Inc., Xcelris Genomics, Trimgen Corporation, and Illumina, Inc. are a few leading companies operating in the global Genotyping market are among the key players operating in the Genotyping market. For instance, in January 2021, Thermo Fisher Scientific Inc. launched the Orbitrap Exploris MX Mass Detector for new-generation mass spectrometry instruments, workflows, and software.
The use of genotyping in drug development for genetic & rare diseases and rising R&D investments in pharmaceutical & biotechnology boost the global genotyping market growth.
According to the Alzheimer's Association, in 2022, the number of people living with Alzheimer's in the US rapidly increases. Alzheimer's affects more than 6 million Americans of all ages. In 2022, an estimated 6.5 million Americans aged 65 and up have Alzheimer's, out of which 73% of the population is 75 years old or older.
Purchase a Copy of this Report: https://www.theinsightpartners.com/buy/TIPHE100001166/?utm_source=OpenPR&utm_medium=10357
About Us:
The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, chemicals etc.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Genotyping Market Size to Hit US$ 79,407.14 million by 2028 here
News-ID: 2792225 • Views: …
More Releases from The Insight Parntners
The Ultimate PDF Guide to Spinal Imaging
Spinal imaging is a critical diagnostic tool used to evaluate the structure and condition of the spine, including the vertebrae, intervertebral discs, spinal cord, and surrounding tissues. Techniques such as X-ray, MRI, and CT scans help detect abnormalities like fractures, herniated discs, tumors, infections, or degenerative diseases. It provides detailed visualization, enabling early diagnosis and effective treatment planning for conditions affecting the cervical, thoracic, and lumbar regions of the spine.…
Power over Ethernet (PoE) Market Poised for Significant Growth Amid Rising Deman …
10 October 2025 - [New York, US] - The global Power over Ethernet (PoE) market is witnessing remarkable growth, driven by the surging adoption of smart building technologies, IoT-enabled devices, and the need for cost-effective and simplified network infrastructure. PoE technology, which enables data and electrical power transmission over a single Ethernet cable, is transforming the way enterprises deploy and manage networked devices such as IP cameras, wireless access points,…
Respiratory Medical Device Market Positioned for Rapid Growth, Driven by Tech In …
New York, US - September 18, 2025 - A new report from The Insight Partners, titled "Respiratory Medical Device Professional Market - Global Analysis and Forecast," indicates that the global market for respiratory medical devices is poised for significant expansion. The report identifies the rising prevalence of respiratory illnesses, a growing aging population, and continuous technological innovation as key growth drivers.
Check valuable insights in the Respiratory Medical Device Market…
Future of Wind Turbine Components - Complete Guide (PDF)
Growing population and rapid industrialization have driven the demand for wind energy, which is boosting the application of wind turbine components. The rise in energy consumption boosted the need for alternative energy sources, as traditional energy resources such as fossil fuels are directing to environmental pollution. Clean alternative options such as wind emerged to curb immense carbon emissions and their negative impact on the environment, along with the agenda of…
More Releases for Genotyping
Genotyping Market Future Prediction Report By 2031
Genotyping Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics.
Request Sample…
Rising Genetic Disorder Prevalence Drives Growth in the Genotyping Assay Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Genotyping Assay Market Size Growth Forecast: What to Expect by 2025?
In recent times, the genotyping assay market has witnessed significant expansion. The market value is projected to rise from $33.98 billion in 2024 to $41.6 billion in 2025, indicating a compound annual growth rate (CAGR) of 22.4%. Factors…
The Surge In Cancer And Genetic Disorders Fuels Genotyping Market Expansion: Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Genotyping Market Size By 2025?
The market size for genotyping has seen a swift expansion in the recent past. Its growth will continue to accelerate from $23.04 billion in 2024, reaching $26.63 billion in 2025, with a compound annual growth rate (CAGR) of 15.6%. The…
Top Factor Driving Genotyping Market Growth in 2025: The Surge In Cancer And Gen …
How Are the key drivers contributing to the expansion of the genotyping market?
The escalating occurrence of cancer and genetic abnormalities is anticipated to drive the genotyping market's expansion. A myriad of diseases falling under the broad term 'cancer' can originate from virtually any tissue or organ in the body. Genetic disorders, meanwhile, are conditions that are completely or largely caused by deviations in the normal DNA sequence. Genotyping enables researchers…
Genotyping Assay Market worth $37.1 billion by 2029
The major players in this market are Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Danaher Corporation (US), QIAGEN (Netherlands), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (US)
The global genotyping assay market [https://www.marketsandmarkets.com/Market-Reports/genotyping-market-249958595.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr], valued at US$17.4 billion in 2023, is forecasted to grow at a robust CAGR of 13.8%, reaching US$19.4 billion in 2024 and an impressive US$37.1 billion by 2029. This growth is driven by…
Single Nucleotide Polymorphisms Genotyping Market - Unraveling Genetic Codes, Un …
Newark, New Castle, USA - new report, titled Single Nucleotide Polymorphisms Genotyping Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Single Nucleotide Polymorphisms Genotyping market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Single Nucleotide Polymorphisms Genotyping market. The report offers…
